Long Noncoding RNA CEBPA-DT Promotes Cisplatin Chemo-resistance Through CEBPA/BCL2 Mediated Apoptosis in Oral Squamous Cellular Cancer

Overview

Journal Int J Med Sci

Specialty General Medicine

Date 2021 Nov 18

PMID 34790046

Citations 6

Authors

Xue Qiao

Jiayi Liu

Li Zhu

Rongbo Song

Ming Zhong

Yan Guo

Affiliations

Soon will be listed here.

Abstract

Intrinsic or developing resistance to chemotherapy drugs including cisplatin (CDDP) remains the major limitation of cancer therapeutic efficacy in cancers. Recently, increasing evidence suggested that long noncoding RNAs (lncRNAs) play a critical role in various biological processes of tumors, and have been implicated in resistance to various drugs. However, the role of lncRNAs in cisplatin resistance is poorly understood. Here, we found that the expression of lncRNA CEBPA-DT/CEBPA/BCL2 was upregulated in cisplatin resistance OSCC cells (Cal27-CisR and HSC4-CisR) compared with their parental cells (Cal27 and HSC4). CEBPA-DT overexpression could upregulated both cytoplasmic and nuclear CEBPA expression. Down-regulation of CEBPA-DT enhances cisplatin sensitivity, facilitates cell apoptosis in cisplatin-resistant OSCC cells. In addition, we identified that CEBPA-DT regulates cisplatin chemosensitivity through CEBPA/BCL2-mediated cell apoptosis. Knockdown of CEBPA and BCL2 could alleviate the increasement of cisplatin resistance induced by CEBPA-DT overexpression. Our findings indicate that downregulation of lncRNA CEBPA-DT may be a potential therapy to overcome cisplatin resistance in OSCC.

Citing Articles

MAFB-mediated CEBPA regulated human urothelium growth through Wnt/β-catenin signaling pathway.

Liu Z, Luo X, Zhang Z, Zhang Q, Wang C, Chen H Genes Dis. 2024; 12(1):101432.

PMID: 39569391 PMC: 11577151. DOI: 10.1016/j.gendis.2024.101432.

Gene Expression Regulation and the Signal Transduction of Programmed Cell Death.

Saqirile , Deng Y, Li K, Yan W, Li K, Wang C Curr Issues Mol Biol. 2024; 46(9):10264-10298.

PMID: 39329964 PMC: 11430711. DOI: 10.3390/cimb46090612.

Targeting ferroptosis as a potential strategy to overcome the resistance of cisplatin in oral squamous cell carcinoma.

Chen R, Zhu S, Zhao R, Liu W, Jin L, Ren X Front Pharmacol. 2024; 15:1402514.

PMID: 38711989 PMC: 11071065. DOI: 10.3389/fphar.2024.1402514.

LncRNA CEBPA-DT promotes liver cancer metastasis through DDR2/β-catenin activation via interacting with hnRNPC.

Cai Y, Lyu T, Li H, Liu C, Xie K, Xu L J Exp Clin Cancer Res. 2022; 41(1):335.

PMID: 36471363 PMC: 9724427. DOI: 10.1186/s13046-022-02544-6.

Emerging role of lncRNAs in drug resistance mechanisms in head and neck squamous cell carcinoma.

Pena-Flores J, Bermudez M, Ramos-Payan R, Villegas-Mercado C, Soto-Barreras U, Muela-Campos D Front Oncol. 2022; 12:965628.

PMID: 35978835 PMC: 9376329. DOI: 10.3389/fonc.2022.965628.

References

Pabst T, Mueller B . Complexity of CEBPA dysregulation in human acute myeloid leukemia. Clin Cancer Res. 2009; 15(17):5303-7. DOI: 10.1158/1078-0432.CCR-08-2941. View

Zhang L, Meng X, Zhu X, Yang D, Chen R, Jiang Y . Long non-coding RNAs in Oral squamous cell carcinoma: biologic function, mechanisms and clinical implications. Mol Cancer. 2019; 18(1):102. PMC: 6535863. DOI: 10.1186/s12943-019-1021-3. View

Tomizawa M, Horie H, Yamamoto H, Matsunaga T, Sasaki F, Hashizume K . Reciprocal expression of CCAAT/enhancer binding proteins alpha and beta in hepatoblastomas and its prognostic significance. Oncol Rep. 2007; 17(2):341-4. View

Li S, Wu Y, Ding Y, Yu M, Ai Z . CerS6 regulates cisplatin resistance in oral squamous cell carcinoma by altering mitochondrial fission and autophagy. J Cell Physiol. 2018; 233(12):9416-9425. DOI: 10.1002/jcp.26815. View

Fang Z, Zhao J, Xie W, Sun Q, Wang H, Qiao B . LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression. Cancer Med. 2017; 6(12):2897-2908. PMC: 5727307. DOI: 10.1002/cam4.1253. View

Hardie M, Kava H, Murray V . Cisplatin Analogues with an Increased Interaction with DNA: Prospects for Therapy. Curr Pharm Des. 2016; 22(44):6645-6664. DOI: 10.2174/1381612822666160831101529. View

Lau A, Li K, Yang W, Su Y . Induction chemotherapy for squamous cell carcinomas of the oral cavity: A cumulative meta-analysis. Oral Oncol. 2016; 61:104-14. DOI: 10.1016/j.oraloncology.2016.08.022. View

Ke D, Li H, Zhang Y, An Y, Fu H, Fang X . The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer. Oncotarget. 2017; 8(13):21516-21525. PMC: 5400602. DOI: 10.18632/oncotarget.15628. View

Arrial R, Togawa R, Brigido M . Screening non-coding RNAs in transcriptomes from neglected species using PORTRAIT: case study of the pathogenic fungus Paracoccidioides brasiliensis. BMC Bioinformatics. 2009; 10:239. PMC: 2731755. DOI: 10.1186/1471-2105-10-239. View

10.

Wang X, Liu W, Wang P, Li S . RNA interference of long noncoding RNA HOTAIR suppresses autophagy and promotes apoptosis and sensitivity to cisplatin in oral squamous cell carcinoma. J Oral Pathol Med. 2018; 47(10):930-937. DOI: 10.1111/jop.12769. View

11.

Momen-Heravi F, Bala S . Emerging role of non-coding RNA in oral cancer. Cell Signal. 2017; 42:134-143. DOI: 10.1016/j.cellsig.2017.10.009. View

12.

Wang J, Li L, Wu K, Ge W, Zhang Z, Gong L . Knockdown of long noncoding RNA urothelial cancer-associated 1 enhances cisplatin chemosensitivity in tongue squamous cell carcinoma cells. Pharmazie. 2018; 71(10):598-602. DOI: 10.1691/ph.2016.6625. View

13.

Lu G, Leung C, Yan B, Tan C, Low S, Aung M . C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation. Gastroenterology. 2010; 139(2):632-43, 643.e1-4. DOI: 10.1053/j.gastro.2010.03.051. View

14.

Krishna Rao S, Mejia G, Roberts-Thomson K, Logan R . Epidemiology of oral cancer in Asia in the past decade--an update (2000-2012). Asian Pac J Cancer Prev. 2013; 14(10):5567-77. DOI: 10.7314/apjcp.2013.14.10.5567. View

15.

Zhou Y, Sun W, Qin Z, Guo S, Kang Y, Zeng S . LncRNA regulation: New frontiers in epigenetic solutions to drug chemoresistance. Biochem Pharmacol. 2020; 189:114228. DOI: 10.1016/j.bcp.2020.114228. View

16.

Xiao T, Liu L, Li H, Sun Y, Luo H, Li T . Long Noncoding RNA ADINR Regulates Adipogenesis by Transcriptionally Activating C/EBPα. Stem Cell Reports. 2015; 5(5):856-865. PMC: 4649137. DOI: 10.1016/j.stemcr.2015.09.007. View

17.

Shen C, Yang C, Xia B, You M . Long non-coding RNAs: Emerging regulators for chemo/immunotherapy resistance in cancer stem cells. Cancer Lett. 2020; 500:244-252. DOI: 10.1016/j.canlet.2020.11.010. View

18.

Xie W, Chu M, Song G, Zuo Z, Han Z, Chen C . Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer. Semin Cancer Biol. 2020; 83:303-318. DOI: 10.1016/j.semcancer.2020.11.004. View

19.

Shang C, Ao C, Cheong C, Meng L . Long Non-coding RNA CDKN2B Antisense RNA 1 Gene Contributes to Paclitaxel Resistance in Endometrial Carcinoma. Front Oncol. 2019; 9:27. PMC: 6361746. DOI: 10.3389/fonc.2019.00027. View

20.

Zhu L, Zhu Y, Han S, Chen M, Song P, Dai D . Impaired autophagic degradation of lncRNA ARHGAP5-AS1 promotes chemoresistance in gastric cancer. Cell Death Dis. 2019; 10(6):383. PMC: 6522595. DOI: 10.1038/s41419-019-1585-2. View